首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: clinical case and experimental study on porcine lung explants.
【24h】

Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: clinical case and experimental study on porcine lung explants.

机译:流体动力血栓切除术装置经静脉肺栓塞切除术后可疑的肺动脉破裂:猪肺外植体的临床病例和实验研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To use porcine lung explants for reconstructing possible situations in which a vessel wall disruption might have occurred in a patient suffering fatal hemoptysis after pulmonary embolectomy with a hydrodynamic thrombectomy device. Methods: A 76-year-old woman with massive pulmonary embolism underwent transvenous pulmonary embolectomy using a 6-F AngioJet Xpeedior catheter according to manufacturer's instructions. While activating the device in the middle lobe artery ( approximately 8 mm diameter), massive and ultimately fatal arterial bleeding occurred through the tracheal tube. Because no autopsy was authorized, an experimental study was designed to examine possible causes for the vessel disruption. Five fresh porcine heart-lung preparations were examined inside a dedicated chest phantom. Access to the pulmonary vessels was provided through catheters inside the right and left ventricular outlets. A low-flow circulation was maintained with an external pump. The 6-F AngioJet thrombectomy devicewas activated at 42 sites inside vessels from 2 to 10 mm in diameter; in one lung, 8 activations were made after deliberately withdrawing the guidewire. Results: Vessels >6 mm in diameter remained intact. Vessel wall disruption occurred in 4 of 7 vessels between 4 and 6 mm in diameter and in 13 of 14 segmental arteries <4 mm in diameter (regardless of whether or not a guidewire was used). The signs of vessel wall disruption included extravasation of contrast material, arteriovenous fistula, and laceration of distal airspaces with contrast inside the bronchus. Conclusions: The application of this system has to be considered potentially dangerous when activated inside vessels with diameters <6 mm. The use of this device appears to be safe only inside main branches of the lung vessels at this time. Additional experiments will be required to substantiate these initial results.
机译:目的:使用猪肺外植体来重建可能的情况,在这种情况下,在使用液压动力血栓切除术装置进行肺栓塞切除术的致命性咯血患者中可能发生血管壁破裂。方法:根据制造商的说明,使用6-F AngioJet Xpeedior导管对一名患有严重肺栓塞的76岁妇女进行静脉肺栓塞切除术。在中叶动脉(直径约8毫米)中激活该设备时,通过气管导管发生了大规模的致命性动脉出血。由于没有进行尸检的授权,因此设计了一项实验研究来检查血管破裂的可能原因。在专用的胸模内检查了五种新鲜的猪心肺制剂。通过左右心室出口内的导管进入肺血管。用外部泵维持低流量循环。 6-F AngioJet血栓切除装置在直径2至10毫米的血管内的42个部位被激活。在一只肺中,有意抽出导丝后进行了8次激活。结果:直径> 6 mm的船只保持完整。直径在4到6毫米之间的7根血管中有4根发生血管壁破裂,直径<4毫米的14条段动脉中有13根发生血管壁破裂(无论是否使用导丝)。血管壁破裂的迹象包括造影剂外渗,动静脉瘘和远端气隙撕裂,支气管内部有造影剂。结论:在直径小于6mm的容器内激活该系统时,必须考虑该系统的潜在危险。目前,仅在肺血管的主要分支内使用此设备似乎是安全的。需要进一步的实验来证实这些初步结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号